Bookmark this page

Independent effect of depression on inflammatory markers as compared to natural killer cell activity
It is recognized that the functioning of the immune system is altered in major depressive disorder which leads to an increased risk of infectious disease and incidence of inflammatory disorders. A reduction of natural killer (NK) cell activity in depression has been reported by some studies, whereas increases of inflammatory markers have been found in others. However, NK activity and inflammation, and their potential association have never been simultaneously examined in depression. A study evaluated levels of NK activity and markers of immune activation in depressed patients compared to age-, gender, and body weight matched controls.
The total sample included 25 patients with current major depressive disorder and 25 control subjects, all individuals were male. Mononuclear cells were isolated from peripheral blood and NK cell activity was assayed. Serum levels of interleukin-6 (IL-6), soluble interleukin-2 receptor (sIL-2R), and acute phase proteins (haptoglobin, alpha-1-anti-trypsin (AAT), and alpha-1-acid glycoprotein (AAG)) were measured.
Compared to controls, NK activity was significantly lower in the depressed patients (p = 0.05). In contrast, circulating levels of IL-6 were elevated in the depressives compared to controls (p < 0.05). Serum levels of sIL-2R, haptoglobin, AAT, and AAG did not differ between the two groups. There was no correlation between NK activity and levels of IL-6, sIL-2R, haptoglobin, AAT or AAG.
From these results there is evidence for increased inflammatory markers in major depression which is not correlated with reduction of NK cell responses. The independent effect of depression on NK immune responses as compared to inflammatory markers may explain the different individual reactions to the major depressive disorder, particularly the differences in its adverse health effects.
Pike JL, Irwin MR. Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder. Brain Behav Immun 2006, 20:169-174.

Disclaimer

Site conceived and produced by NeuroBiz Consulting & Communications
Copyright © Depression-WebWorld Ltd UK, 2006